1.
Sharaf Eldeen DAM, Abdelgawad AE. Gemcitabine and vinorelbine: treatment option in recurrent platinum – resistant ovarian cancer. Eur J Oncol Environ Health [Internet]. 2018 Mar. 29 [cited 2021 Oct. 27];22(3-4):131-7. Available from: https://www.mattioli1885journals.com/index.php/EJOEH/article/view/6086